<!DOCTYPE article PUBLIC "-//NLM//DTD JATS (Z39.96) Journal Archiving and Interchange DTD v1.0 20120330//EN" "JATS-archivearticle1.dtd">
<article xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" article-type="research-article"><?properties open_access?><front><journal-meta><journal-id journal-id-type="nlm-ta">Braz J Cardiovasc Surg</journal-id><journal-id journal-id-type="iso-abbrev">Braz J Cardiovasc Surg</journal-id><journal-id journal-id-type="publisher-id">rbccv</journal-id><journal-title-group><journal-title>Brazilian Journal of Cardiovascular Surgery</journal-title></journal-title-group><issn pub-type="ppub">0102-7638</issn><issn pub-type="epub">1678-9741</issn><publisher><publisher-name>Sociedade Brasileira de Cirurgia Cardiovascular</publisher-name></publisher></journal-meta><article-meta><article-id pub-id-type="pmid">31454193</article-id><article-id pub-id-type="pmc">6713365</article-id><article-id pub-id-type="doi">10.21470/1678-9741-2019-0170</article-id><article-categories><subj-group subj-group-type="heading"><subject>Original Article</subject></subj-group></article-categories><title-group><article-title>Coronary Artery Bypass Graft Surgery Improves Survival Without
Increasing the Risk of Stroke in Patients with Ischemic Heart Failure in
Comparison to Percutaneous Coronary Intervention: A Meta-Analysis With 54,173
Patients</article-title></title-group><contrib-group><contrib contrib-type="author"><contrib-id contrib-id-type="orcid" authenticated="false">http://orcid.org/0000-0001-5356-2996</contrib-id><name><surname>S&#x000e1;</surname><given-names>Michel Pompeu Barros Oliveira</given-names></name><xref ref-type="aff" rid="aff1">1</xref><xref ref-type="aff" rid="aff2">2</xref><xref ref-type="aff" rid="aff3">3</xref><xref ref-type="corresp" rid="c1"/><role>MD MSc, PhD</role></contrib><contrib contrib-type="author"><name><surname>Perazzo</surname><given-names>&#x000c1;lvaro Monteiro</given-names></name><xref ref-type="aff" rid="aff1">1</xref><xref ref-type="aff" rid="aff2">2</xref><role>MD</role></contrib><contrib contrib-type="author"><name><surname>Saragiotto</surname><given-names>Felipe Augusto Santos</given-names></name><xref ref-type="aff" rid="aff1">1</xref><xref ref-type="aff" rid="aff2">2</xref><role>MD</role></contrib><contrib contrib-type="author"><name><surname>Cavalcanti</surname><given-names>Luiz Rafael Pereira</given-names></name><xref ref-type="aff" rid="aff1">1</xref><xref ref-type="aff" rid="aff2">2</xref><role>MD</role></contrib><contrib contrib-type="author"><name><surname>Almeida Neto</surname><given-names>Ant&#x000f4;nio Carlos Escorel</given-names></name><xref ref-type="aff" rid="aff1">1</xref><xref ref-type="aff" rid="aff2">2</xref><role>MD</role></contrib><contrib contrib-type="author"><name><surname>Campos</surname><given-names>J&#x000e9;ssica Cordeiro Siqueira</given-names></name><xref ref-type="aff" rid="aff1">1</xref><xref ref-type="aff" rid="aff2">2</xref><role>MD</role></contrib><contrib contrib-type="author"><name><surname>Braga</surname><given-names>Paulo Guilherme Bezerra</given-names></name><xref ref-type="aff" rid="aff1">1</xref><xref ref-type="aff" rid="aff2">2</xref><role>MD</role></contrib><contrib contrib-type="author"><name><surname>Rayol</surname><given-names>S&#x000e9;rgio da Costa</given-names></name><xref ref-type="aff" rid="aff1">1</xref><xref ref-type="aff" rid="aff2">2</xref><role>MD</role></contrib><contrib contrib-type="author"><name><surname>Diniz</surname><given-names>Roberto Gouvea Silva</given-names></name><xref ref-type="aff" rid="aff1">1</xref><xref ref-type="aff" rid="aff2">2</xref><role>MD</role></contrib><contrib contrib-type="author"><name><surname>S&#x000e1;</surname><given-names>Frederico Browne Correia Ara&#x000fa;jo</given-names></name><xref ref-type="aff" rid="aff1">1</xref><xref ref-type="aff" rid="aff2">2</xref><role>MD</role></contrib><contrib contrib-type="author"><name><surname>Lima</surname><given-names>Ricardo Carvalho</given-names></name><xref ref-type="aff" rid="aff1">1</xref><xref ref-type="aff" rid="aff2">2</xref><xref ref-type="aff" rid="aff3">3</xref><role>MD, MSc, PhD, ChM, AATS</role></contrib></contrib-group><aff id="aff1"><label>1</label> Division of Cardiovascular Surgery, Pronto Socorro
Cardiol&#x000f3;gico de Pernambuco - PROCAPE, Recife, Pernambuco, Brazil.</aff><aff id="aff2"><label>2</label> University of Pernambuco - UPE, Recife, Pernambuco,
Brazil.</aff><aff id="aff3"><label>3</label> Nucleus of Postgraduate and Research in Health Sciences,
Faculty of Medical Sciences and Biological Sciences Institute - FCM/ICB, Recife,
Pernambuco, Brazil.</aff><author-notes><corresp id="c1">Correspondence Address: Michel Pompeu Barros de Oliveira S&#x000e1;,
https://orcid.org/0000-0001-5356-2996, Pronto-Socorro Cardiol&#x000f3;gico de
Pernambuco (PROCAPE), Rua dos Palmares, S/N - Santo Amaro - Recife, PE, Brazil -
Zip code: 74970-240. E-mail: <email>michel_pompeu@yahoo.com.br</email></corresp></author-notes><pub-date pub-type="epub-ppub"><season>Jul-Aug</season><year>2019</year></pub-date><!--Fake ppub date generated by PMC from publisher
							pub-date/@pub-type='epub-ppub' --><pub-date pub-type="ppub"><season>Jul-Aug</season><year>2019</year></pub-date><volume>34</volume><issue>4</issue><fpage>396</fpage><lpage>405</lpage><history><date date-type="received"><day>27</day><month>4</month><year>2019</year></date><date date-type="accepted"><day>25</day><month>6</month><year>2019</year></date></history><permissions><license license-type="open-access" xlink:href="http://creativecommons.org/licenses/by/4.0/"><license-p>This is an Open Access article distributed under the terms of the
Creative Commons Attribution License, which permits unrestricted use,
distribution, and reproduction in any medium, provided the original work is
properly cited.</license-p></license></permissions><abstract><sec><title>Objective</title><p>To evaluate whether there is any difference on the results of patients
treated with coronary artery bypass grafting (CABG) or percutaneous coronary
intervention (PCI) in the setting of ischemic heart failure (HF).</p></sec><sec><title>Methods</title><p>Databases (MEDLINE, Embase, Cochrane Controlled Trials Register
[CENTRAL/CCTR], ClinicalTrials.gov, Scientific Electronic
Library Online [SciELO], Literatura Latino-americana e do
Caribe em Ci&#x000ea;ncias da Sa&#x000fa;de [LILACS], and Google
Scholar) were searched for studies published until February 2019. Main
outcomes of interest were mortality, myocardial infarction, repeat
revascularization, and stroke.</p></sec><sec><title>Results</title><p>The search yielded 5,775 studies for inclusion. Of these, 20 articles were
analyzed, and their data were extracted. The total number of patients
included was 54,173, and those underwent CABG (N=29,075) or PCI (N=25098).
The hazard ratios (HRs) for mortality (HR 0.763; 95% confidence interval
[CI] 0.678-0.859; <italic>P</italic>&#x0003c;0.001), myocardial
infarction (HR 0.481; 95% CI 0.365-0.633; <italic>P</italic>&#x0003c;0.001), and
repeat revascularization (HR 0.321; 95% CI 0.241-0.428;
<italic>P</italic>&#x0003c;0.001) were lower in the CABG group than in the PCI
group. The HR for stroke showed no statistically significant difference
between the groups (random effect model: HR 0.879; 95% CI 0.625-1.237;
<italic>P</italic>=0.459).</p></sec><sec><title>Conclusion</title><p>This meta-analysis found that CABG surgery remains the best option for
patients with ischemic HF, without increase in the risk of stroke.</p></sec></abstract><kwd-group><kwd>Meta-Analysis</kwd><kwd>Coronary Artery Bypass</kwd><kwd>Stents</kwd><kwd>Percutaneous Coronary Intervention</kwd><kwd>Heart Failure</kwd></kwd-group></article-meta></front><body><table-wrap id="t1" orientation="portrait" position="anchor"><table frame="hsides" rules="groups"><colgroup span="1"><col width="5%" span="1"/><col width="42%" span="1"/><col width="5%" span="1"/><col width="5%" span="1"/><col width="42%" span="1"/></colgroup><thead><tr><th align="left" colspan="2" style="background-color:#e6e7e8" rowspan="1">Abbreviations,
acronyms &#x00026; symbols</th><th align="center" rowspan="1" colspan="1">&#x000a0;</th><th align="left" style="background-color:#e6e7e8" rowspan="1" colspan="1">&#x000a0;</th><th align="left" style="background-color:#e6e7e8" rowspan="1" colspan="1">&#x000a0;</th></tr></thead><tbody><tr><td align="left" style="background-color:#e6e7e8" rowspan="1" colspan="1">CABG</td><td align="left" style="background-color:#e6e7e8" rowspan="1" colspan="1">= Coronary artery bypass
grafting</td><td align="center" rowspan="1" colspan="1">&#x000a0;</td><td align="left" style="background-color:#e6e7e8" rowspan="1" colspan="1">LVEF</td><td align="left" style="background-color:#e6e7e8" rowspan="1" colspan="1">= Left ventricular
ejection fraction</td></tr><tr><td align="left" style="background-color:#e6e7e8" rowspan="1" colspan="1">CENTRAL/CCTR</td><td align="left" style="background-color:#e6e7e8" rowspan="1" colspan="1">= Cochrane Controlled
Trials Register</td><td align="center" rowspan="1" colspan="1">&#x000a0;</td><td align="left" style="background-color:#e6e7e8" rowspan="1" colspan="1">MeSH</td><td align="left" style="background-color:#e6e7e8" rowspan="1" colspan="1">= Medical subject
headings</td></tr><tr><td align="left" style="background-color:#e6e7e8" rowspan="1" colspan="1">CI</td><td align="left" style="background-color:#e6e7e8" rowspan="1" colspan="1">= Confidence interval</td><td align="center" rowspan="1" colspan="1">&#x000a0;</td><td align="left" style="background-color:#e6e7e8" rowspan="1" colspan="1">MI</td><td align="left" style="background-color:#e6e7e8" rowspan="1" colspan="1">= Myocardial
infarction</td></tr><tr><td align="left" style="background-color:#e6e7e8" rowspan="1" colspan="1">EACTS</td><td align="left" style="background-color:#e6e7e8" rowspan="1" colspan="1">= European Association for
Cardio-Thoracic Surgery</td><td align="center" rowspan="1" colspan="1">&#x000a0;</td><td align="left" style="background-color:#e6e7e8" rowspan="1" colspan="1">PCI</td><td align="left" style="background-color:#e6e7e8" rowspan="1" colspan="1">= Percutaneous coronary
intervention</td></tr><tr><td align="left" style="background-color:#e6e7e8" rowspan="1" colspan="1">EF</td><td align="left" style="background-color:#e6e7e8" rowspan="1" colspan="1">= Ejection fraction</td><td align="center" rowspan="1" colspan="1">&#x000a0;</td><td align="left" style="background-color:#e6e7e8" rowspan="1" colspan="1">PICOS</td><td align="left" style="background-color:#e6e7e8" rowspan="1" colspan="1">= Population,
Intervention, Comparison, Outcome and Study Design</td></tr><tr><td align="left" style="background-color:#e6e7e8" rowspan="1" colspan="1">ESC</td><td align="left" style="background-color:#e6e7e8" rowspan="1" colspan="1">= European Society of
Cardiology</td><td align="center" rowspan="1" colspan="1">&#x000a0;</td><td align="left" style="background-color:#e6e7e8" rowspan="1" colspan="1">PRISMA</td><td align="left" style="background-color:#e6e7e8" rowspan="1" colspan="1">= Preferred Reporting
Items for Systematic Reviews and Meta-Analyses</td></tr><tr><td align="left" style="background-color:#e6e7e8" rowspan="1" colspan="1">HF</td><td align="left" style="background-color:#e6e7e8" rowspan="1" colspan="1">= Heart failure</td><td align="center" rowspan="1" colspan="1">&#x000a0;</td><td align="left" style="background-color:#e6e7e8" rowspan="1" colspan="1">SciELO</td><td align="left" style="background-color:#e6e7e8" rowspan="1" colspan="1">= Scientific Electronic
Library Online</td></tr><tr><td align="left" style="background-color:#e6e7e8" rowspan="1" colspan="1">HR</td><td align="left" style="background-color:#e6e7e8" rowspan="1" colspan="1">= Hazard ratio</td><td align="center" rowspan="1" colspan="1">&#x000a0;</td><td align="left" style="background-color:#e6e7e8" rowspan="1" colspan="1">&#x000a0;</td><td align="left" style="background-color:#e6e7e8" rowspan="1" colspan="1">&#x000a0;</td></tr><tr><td align="left" style="background-color:#e6e7e8" rowspan="1" colspan="1">LILACS</td><td align="left" style="background-color:#e6e7e8" rowspan="1" colspan="1">= Literatura
Latino-americana e do Caribe em Ci&#x000ea;ncias da Sa&#x000fa;de</td><td align="center" rowspan="1" colspan="1">&#x000a0;</td><td align="left" style="background-color:#e6e7e8" rowspan="1" colspan="1">&#x000a0;</td><td align="left" style="background-color:#e6e7e8" rowspan="1" colspan="1">&#x000a0;</td></tr></tbody></table></table-wrap><sec sec-type="intro"><title>INTRODUCTION</title><sec><title>Rationale</title><p>Recent European Society of Cardiology (ESC) and European Association for
Cardio-Thoracic Surgery (EACTS) guidelines on myocardial
revascularization<sup>[<xref rid="r1" ref-type="bibr">1</xref>]</sup> clearly recommended coronary artery bypass grafting
(CABG) as the first choice of revascularization strategy in patients with
multivessel disease and acceptable surgical risk to improve prognosis in this
scenario of left ventricular dysfunction.</p><p>According to guidelines from the United States of America<sup>[<xref rid="r2" ref-type="bibr">2</xref>,<xref rid="r3" ref-type="bibr">3</xref>]</sup>, revascularization strategies might be
beneficial in the context of left ventricular dysfunction. CABG surgery would be
class of recommendation IIa for those with moderate left ventricular dysfunction
and IIb for those with left ventricular ejection fraction (LVEF) &#x02264;35%
without significant left main coronary artery disease. There is not enough data
about the percutaneous coronary intervention (PCI) to allow the panels to reach
any conclusion nor make any recommendation in this setting. Nevertheless, some
studies<sup>[<xref rid="r4" ref-type="bibr">4</xref>,<xref rid="r5" ref-type="bibr">5</xref>]</sup> have suggested that PCI
could provide comparable outcomes to CABG in patients with heart failure (HF).
In light of these studies, we decided to perform a systematic review with
meta-analysis in order to evaluate comparatively the impact of CABG and PCI on
the rates of complications and mortality of patients with ischemic HF.</p></sec><sec><title>Objectives</title><p>We aimed to investigate whether there is any difference on the results of
patients treated with CABG or PCI in the setting of ischemic HF. This analysis
was planned in accordance with current guidelines for performing comprehensive
systematic reviews and meta-analysis, including the Preferred Reporting Items
for Systematic Reviews and Meta-Analyses (PRISMA)<sup>[<xref rid="r6" ref-type="bibr">6</xref>]</sup> guidelines.</p></sec></sec><sec sec-type="methods"><title>METHODS</title><sec><title>Eligibility Criteria</title><p>Using Population, Intervention, Comparison, Outcome and Study Design (PICOS)
strategy, studies were considered eligible if: (1) the population comprised
patients with ischemic HF with impaired ejection fraction (EF); (2) there was
compared efficacy between CABG and PCI; (3) the studied outcomes have included
death, myocardial infarction (MI), stroke, or repeat revascularization; (4)
there was a follow-up of at least 12 months. There was no restriction on
language and the studies were of any type (retrospective/prospective, randomized
or non-randomized, multicentric or not).</p></sec><sec><title>Information Sources</title><p>The following databases were used (until February 2019): MEDLINE, Embase, the
Cochrane Controlled Trials Register (CENTRAL/CCTR), ClinicalTrials.gov, the
Scientific Electronic Library Online (SciELO), Literatura Latino-americana e do
Caribe em Ci&#x000ea;ncias da Sa&#x000fa;de (LILACS), Google Scholar, and
reference lists of relevant articles.</p></sec><sec><title>Search</title><p>The following terms according to the medical subject headings (MeSH) terms
included revascularization, impaired ejection fraction, LVEF, severe left
ventricular dysfunction, reduced ejection fraction, heart failure, ischemic
cardiomyopathy, percutaneous coronary intervention, and coronary artery bypass
grafting surgery.</p></sec><sec><title>Study Selection</title><p>The following steps were taken: 1) identification of titles of records through
databases searching; 2) removal of duplicates; 3) screening and selection of
abstracts; 4) assessment for eligibility through full-text articles; and 5)
final inclusion in study. One reviewer followed steps 1 to 3. Two independent
reviewers followed step 4 and selected studies. Inclusion or exclusion of
studies was decided unanimously. When there was disagreement, a third reviewer
made the final decision.</p></sec><sec><title>Data Items</title><p>The crude endpoints were mortality, MI, stroke, and repeat revascularization.</p></sec><sec><title>Data Collection Process</title><p>Two independent reviewers extracted the data. When there was disagreement about
the data, a third reviewer checked them and made the final decision. From each
study, we extracted patients&#x02019; characteristics, study design, and outcomes. When
the data were not clearly available in the articles, we contacted the authors of
the original articles by e-mail.</p></sec><sec><title>Summary Measures</title><p>The principal summary measures were hazard ratio (HR) with 95% confidence
interval (CI) and <italic>P</italic>-values (considered statistically
significant when <italic>P</italic>&#x0003c;0.05) for mortality and difference in
means for the other outcomes. The meta-analysis was completed with the
Comprehensive Meta-Analysis software (version 2, Biostat, Inc., Englewood, New
Jersey).</p></sec><sec><title>Synthesis of Results</title><p>Forest plots were generated for graphical presentations of clinical outcomes, and
we performed I<sup>2</sup> test and &#x003c7;<sup>2</sup> test for the assessment
of heterogeneity across the studies<sup>[<xref rid="r7" ref-type="bibr">7</xref>]</sup>. Inter-study heterogeneity was explored using
the &#x003c7;<sup>2</sup> statistic, but the I<sup>2</sup>-value was calculated
to quantify the degree of heterogeneity across the studies that could not be
attributable to chance alone. When I<sup>2</sup> was more than 50%, significant
statistical heterogeneity was considered to be present. Each study was
summarized by the HR, whose values were combined across the studies using a
weighted DerSimonian-Laird random effects model<sup>[<xref rid="r8" ref-type="bibr">8</xref>]</sup>.</p></sec><sec><title>Risk of Bias Across Studies</title><p>To assess publication bias, a funnel plot was generated for each outcome,
statistically assessed by Begg and Mazumdar&#x02019;s test<sup>[<xref rid="r9" ref-type="bibr">9</xref>]</sup> and Egger&#x02019;s
test<sup>[<xref rid="r10" ref-type="bibr">10</xref>]</sup>.</p></sec><sec><title>Sensitivity Analysis</title><p>We also investigated the influence of each study on the overall effect - by
sequentially removing one study - in order to test the robustness of the main
results, so that we could verify whether any study had an excessive influence on
the overall results.</p></sec></sec><sec sec-type="results"><title>RESULTS</title><sec><title>Study Selection</title><p>A total of 5,775 citations were identified, of which 32 studies were potentially
relevant and retrieved as full text. Twenty publications<sup>[<xref rid="r11" ref-type="bibr">11</xref>-<xref rid="r28" ref-type="bibr">28</xref>]</sup> fulfilled our eligibility criteria.
Interobserver reliability of study relevance was very good (Kappa=0.82).
Agreement for decisions related to study validity was very good (Kappa=0.84).
The search strategy can be seen in <xref ref-type="fig" rid="f1">Figure
1</xref>.</p><p>
<fig id="f1" orientation="portrait" position="float"><label>Fig. 1</label><caption><p>Flow diagram of studies included in data search. CABG=coronary artery
bypass grafting; CENTRAL/CCTR=Cochrane Controlled Trials Register;
LILACS=Literatura Latino-americana e do Caribe em Ci&#x000ea;ncias da
Sa&#x000fa;de; PCI=percutaneous coronary intervention;
SciELO=Scientific Electronic Library Online</p></caption><graphic xlink:href="rbccv-34-04-0396-g01"/></fig>
</p></sec><sec><title>Study Characteristics</title><p>A total of 54,173 patients (CABG: 29,075 patients; PCI: 25,098 patients) were
included, from studies published from 2002 to 2019. The studies consisted of
patients whose mean age was around 65 years. Most of the patients were male in
all the studies. Only two studies were randomized, seven studies were
prospective, and almost all of them were multicentric. Almost all the studies
had patients with LVEF &#x0003c;35%.</p></sec><sec><title>Synthesis of Results</title><p>The HR for mortality in the CABG group compared with that in the PCI group in
each study is reported in <xref ref-type="fig" rid="f2">Figure 2</xref>. There
was evidence of moderate heterogeneity of treatment effect among the studies for
mortality. The overall HR (95% CI) of mortality showed better results in the
CABG group (random effect model: HR 0.763; 95% CI 0.678-0.859;
<italic>P</italic>&#x0003c;0.001) than in the PCI group.</p><p>
<fig id="f2" orientation="portrait" position="float"><label>Fig. 2</label><caption><p>Hazard ratio and conclusions plot of mortality. CABG=coronary artery
bypass grafting; CI=confidence interval; PCI=percutaneous coronary
intervention</p></caption><graphic xlink:href="rbccv-34-04-0396-g02"/></fig>
</p><p>The HR for MI in the CABG group compared with that in the PCI group in each study
is reported in <xref ref-type="fig" rid="f3">Figure 3</xref>. There was evidence
of low heterogeneity of treatment effect among the studies for MI. The overall
HR (95% CI) of MI showed better results in the CABG group (random effect model:
HR 0.481; 95% CI 0.365-0.633; <italic>P</italic>&#x0003c;0.001) than in the PCI
group.</p><p>
<fig id="f3" orientation="portrait" position="float"><label>Fig. 3</label><caption><p>Hazard ratio and conclusions plot of myocardial infarction.
CABG=coronary artery bypass grafting; CI=confidence interval;
PCI=percutaneous coronary intervention</p></caption><graphic xlink:href="rbccv-34-04-0396-g03"/></fig>
</p><p>The HR for repeat revascularization in the CABG group compared with that in the
PCI group in each study is reported in <xref ref-type="fig" rid="f4">Figure
4</xref>. There was evidence of important heterogeneity of treatment effect
among the studies for repeat revascularization. The overall HR (95% CI) of
repeat revascularization showed better results in the CABG group (random effect
model: HR 0.321; 95% CI 0.241-0.428; <italic>P</italic>&#x0003c;0.001) than in the
PCI group.</p><p>
<fig id="f4" orientation="portrait" position="float"><label>Fig. 4</label><caption><p>Hazard ratio and conclusions plot of repeat revascularization.
CABG=coronary artery bypass grafting; CI=confidence interval;
PCI=percutaneous coronary intervention</p></caption><graphic xlink:href="rbccv-34-04-0396-g04"/></fig>
</p><p>The HR for stroke in the CABG group compared with that in the PCI group in each
study is reported in <xref ref-type="fig" rid="f5">Figure 5</xref>. There was
evidence of low heterogeneity of treatment effect among the studies for stroke.
The overall HR (95% CI) of stroke showed no statistically significant difference
between the groups (random effect model: HR 0.879; 95% CI 0.625-1.237;
<italic>P</italic>=0.459).</p><p>
<fig id="f5" orientation="portrait" position="float"><label>Fig. 5</label><caption><p>Hazard ratio and conclusions plot of stroke. CABG=coronary artery
bypass grafting; CI=confidence interval; PCI=percutaneous coronary
intervention</p></caption><graphic xlink:href="rbccv-34-04-0396-g05"/></fig>
</p></sec><sec><title>Risk of Bias Across Studies</title><p>Funnel plot analysis (<xref ref-type="fig" rid="f6">Figure 6</xref>) disclosed no
asymmetry around the axis for the outcomes, which means that there is low risk
of publication bias related to these outcomes.</p><p>
<fig id="f6" orientation="portrait" position="float"><label>Fig. 6</label><caption><p>Publication bias.</p></caption><graphic xlink:href="rbccv-34-04-0396-g06"/></fig>
</p></sec><sec><title>Sensitivity Analysis</title><p>Sensitivity analyses performed by removing each single study from the
meta-analysis (in order to determine the influence of individual data sets on
the pooled HRs) showed that none of the studies had a particular impact on the
summary results of mortality (see <xref ref-type="fig" rid="f7">Figure
7</xref>).</p><p>
<fig id="f7" orientation="portrait" position="float"><label>Fig. 7</label><caption><p>Sensitivity analysis. CABG=coronary artery bypass grafting;
CI=confidence interval; PCI=percutaneous coronary intervention</p></caption><graphic xlink:href="rbccv-34-04-0396-g07"/></fig>
</p></sec></sec><sec sec-type="discussion"><title>DISCUSSION</title><sec><title>Summary of Evidence</title><p>To the best of our knowledge, this is the largest meta-analysis of studies
performed to date that provides additional value by demonstrating that patients
with ischemic HF who underwent CABG surgery have lower risk of mortality, MI,
and repeat revascularization in comparison to those who underwent PCI. CABG did
not increase the risk of stroke in comparison to PCI.</p></sec><sec><title>What Is the Biggest Novelty of This Meta-Analysis?</title><p>Our study stands out from the crowd in that it showed no incremental risk of
stroke in the CABG group in comparison with PCI in the setting of patients with
HF. Several studies have suggested that CABG <italic>vs</italic>. PCI is
associated with a significant increase of procedural stroke<sup>[<xref rid="r29" ref-type="bibr">29</xref>]</sup>, a devastating outcome
with substantial mortality, morbidity, and reduced quality of life. To this
date, there is a lack of conclusive evidence on the exact incidence and
consequences of stroke following either CABG or PCI because individual
randomized trials lacked sufficient power to detect small but meaningful
differences between CABG and PCI<sup>[<xref rid="r30" ref-type="bibr">30</xref>]</sup>. Beyond mortality, it is important to consider
endpoints that significantly impact quality of life, including stroke. The best
evidence currently available is a patient-level meta-analysis published by Head
et al.<sup>[<xref rid="r31" ref-type="bibr">31</xref>]</sup>,
including 11 randomized clinical trials comparing CABG with PCI using stents.
The analysis included 11,518 patients randomly assigned to PCI (N=5,753) or CABG
(N=5,765) with a mean follow-up of 3.8&#x000b1;1.4 years. This individual
patient-data pooled analysis demonstrates that 5-year stroke rates are
significantly lower after PCI compared with CABG, driven by a reduced risk of
stroke in the 30-day post-procedural period, but with a similar risk of stroke
between 31 days and 5 years. The greater risk of stroke after CABG compared with
PCI was confined to patients with multivessel disease and diabetes. Five-year
mortality was markedly higher for patients experiencing a stroke within 30 days
after revascularization. Our study has an almost fourfold increase in sample
size, which increases the power in our study to show a significant difference if
there is one. Therefore, we do not confirm this increase in the risk of stroke
in the setting of patients with HF.</p></sec><sec><title>Risk of Bias and Study Limitations</title><p>There are inherent limitations with meta-analyses, including the use of
cumulative data from summary estimates. Patient data were gathered from
published data, not from individual patient follow-up. Access to individual
patient data would have enabled us to conduct further subgroup analysis and
propensity analysis to account for differences between the treatment groups.
This meta-analysis included data from studies that reflect the &#x0201c;real world&#x0201d; but,
on the other hand, are less limited by publication bias, treatment bias,
confounders, and a certain tendency to overestimate treatment effects observed
in the observational studies, since patient selection alters the outcome and,
thus, makes non-randomized studies less robust.</p><p>Moreover, considerable statistical heterogeneity was observed in some analyses,
but we used the random-effects model to counterbalance this aspect. We also
observed low risk of publication bias in the outcomes. We must remind the
readers of the fact that a research with statistically significant results is
more likely to be submitted to medical journals and published than a work with
null or non-significant results, being the former also more likely to appear
more prominently in English, in higher impact journals. All the aforementioned
aspects lead to the appearance of publication biases, but, in this case, we
cannot state that the impact of CABG in comparison to PCI on morbidity and
mortality rates observed in our study is solely due to bias.</p></sec></sec><sec sec-type="conclusions"><title>CONCLUSION</title><p>This meta-analysis found that CABG surgery remains the best option for patients with
ischemic HF.</p><table-wrap id="t2" orientation="portrait" position="anchor"><table frame="hsides" rules="groups"><colgroup span="1"><col width="5%" span="1"/><col width="95%" span="1"/></colgroup><thead><tr><th align="left" colspan="2" rowspan="1">Authors' roles &#x00026; responsibilities</th></tr></thead><tbody><tr><td align="left" valign="top" rowspan="1" colspan="1">MPBOS</td><td align="left" valign="top" rowspan="1" colspan="1">Substantial contributions to the
conception or design of the work; or the acquisition, analysis, or
interpretation of data for the work; agreement to be accountable for
all aspects of the work in ensuring that questions related to the
accuracy or integrity of any part of the work are appropriately
investigated and resolved; final approval of the version to be
published</td></tr><tr><td align="left" valign="top" rowspan="1" colspan="1">AMP</td><td align="left" valign="top" rowspan="1" colspan="1">Drafting the work or revising it
critically for important intellectual content; agreement to be
accountable for all aspects of the work in ensuring that questions
related to the accuracy or integrity of any part of the work are
appropriately investigated and resolved; final approval of the
version to be published</td></tr><tr><td align="left" valign="top" rowspan="1" colspan="1">FASS</td><td align="left" valign="top" rowspan="1" colspan="1">Drafting the work or revising it
critically for important intellectual content; final approval of the
version to be published</td></tr><tr><td align="left" valign="top" rowspan="1" colspan="1">LRPC</td><td align="left" valign="top" rowspan="1" colspan="1">Drafting the work or revising it
critically for important intellectual content; agreement to be
accountable for all aspects of the work in ensuring that questions
related to the accuracy or integrity of any part of the work are
appropriately investigated and resolved; final approval of the
version to be published</td></tr><tr><td align="left" valign="top" rowspan="1" colspan="1">ACEAN</td><td align="left" valign="top" rowspan="1" colspan="1">Drafting the work or revising it
critically for important intellectual content; final approval of the
version to be published</td></tr><tr><td align="left" valign="top" rowspan="1" colspan="1">JCSC</td><td align="left" valign="top" rowspan="1" colspan="1">Drafting the work or revising it
critically for important intellectual content; final approval of the
version to be published</td></tr><tr><td align="left" valign="top" rowspan="1" colspan="1">PGBB</td><td align="left" valign="top" rowspan="1" colspan="1">Drafting the work or revising it
critically for important intellectual content; final approval of the
version to be published</td></tr><tr><td align="left" valign="top" rowspan="1" colspan="1">SCR</td><td align="left" valign="top" rowspan="1" colspan="1">Drafting the work or revising it
critically for important intellectual content; final approval of the
version to be published</td></tr><tr><td align="left" valign="top" rowspan="1" colspan="1">RGSD</td><td align="left" valign="top" rowspan="1" colspan="1">Drafting the work or revising it
critically for important intellectual content; final approval of the
version to be published</td></tr><tr><td align="left" valign="top" rowspan="1" colspan="1">FBCAS</td><td align="left" valign="top" rowspan="1" colspan="1">Drafting the work or revising it
critically for important intellectual content; agreement to be
accountable for all aspects of the work in ensuring that questions
related to the accuracy or integrity of any part of the work are
appropriately investigated and resolved; final approval of the
version to be published</td></tr><tr><td align="left" valign="top" rowspan="1" colspan="1">RCL</td><td align="left" valign="top" rowspan="1" colspan="1">Drafting the work or revising it
critically for important intellectual content; final approval of the
version to be published</td></tr></tbody></table></table-wrap></sec></body><back><fn-group><fn fn-type="other"><p>This study was carried out at the Division of Cardiovascular Surgery, Pronto
Socorro Cardiol&#x000f3;gico de Pernambuco - PROCAPE, Recife, Pernambuco,
Brazil.</p></fn><fn fn-type="financial-disclosure"><p>No financial support.</p></fn><fn fn-type="COI-statement"><p>No conflict of interest.</p></fn></fn-group><ref-list><title>REFERENCES</title><ref id="r1"><label>1</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Neumann</surname><given-names>FJ</given-names></name><name><surname>Sousa-Uva</surname><given-names>M</given-names></name><name><surname>Ahlsson</surname><given-names>A</given-names></name><name><surname>Alfonso</surname><given-names>F</given-names></name><name><surname>Banning</surname><given-names>AP</given-names></name><name><surname>Benedetto</surname><given-names>U</given-names></name><etal/><collab>ESC scientific document group</collab></person-group><article-title>2018 ESC/EACTS guidelines on myocardial
revascularization</article-title><source>Eur Heart J</source><year>2019</year><volume>40</volume><issue>2</issue><fpage>87</fpage><lpage>165</lpage><pub-id pub-id-type="doi">10.1093/eurheartj/ehy394</pub-id><pub-id pub-id-type="pmid">30165437</pub-id></element-citation></ref><ref id="r2"><label>2</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Yancy</surname><given-names>CW</given-names></name><name><surname>Jessup</surname><given-names>M</given-names></name><name><surname>Bozkurt</surname><given-names>B</given-names></name><name><surname>Butler</surname><given-names>J</given-names></name><name><surname>Casey Jr</surname><given-names>DE</given-names></name><name><surname>Drazner</surname><given-names>MH</given-names></name><etal/></person-group><article-title>2013 ACCF/AHA guideline for the management of heart failure:
executive summary. A report of the American college of cardiology
foundation/American heart association task force on practice
guidelines</article-title><source>Circulation</source><year>2013</year><volume>128</volume><issue>16</issue><fpage>1810</fpage><lpage>1852</lpage><pub-id pub-id-type="doi">10.1161/CIR.0b013e31829e8807</pub-id><pub-id pub-id-type="pmid">23741057</pub-id></element-citation></ref><ref id="r3"><label>3</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Fihn</surname><given-names>SD</given-names></name><name><surname>Gardin</surname><given-names>JM</given-names></name><name><surname>Abrams</surname><given-names>J</given-names></name><name><surname>Berra</surname><given-names>K</given-names></name><name><surname>Blankenship</surname><given-names>JC</given-names></name><name><surname>Dallas</surname><given-names>AP</given-names></name><etal/></person-group><article-title>2012 ACCF/AHA/ACP/AATS/PCNA/SCAI/STS guideline for the diagnosis
and management of patients with stable ischemic heart disease: a report of
the American college of cardiology foundation/American heart association
task force on practice guidelines, and the American college of physicians,
American association for thoracic surgery, preventive cardiovascular nurses
association, society for cardiovascular angiography and interventions, and
society of thoracic surgeons</article-title><source>J Am Coll Cardiol</source><year>2012</year><volume>60</volume><issue>24</issue><fpage>e44</fpage><lpage>e164</lpage><pub-id pub-id-type="doi">10.1016/j.jacc.2012.07.013</pub-id><pub-id pub-id-type="pmid">23182125</pub-id></element-citation></ref><ref id="r4"><label>4</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Yang</surname><given-names>JH</given-names></name><name><surname>Choi</surname><given-names>SH</given-names></name><name><surname>Song</surname><given-names>YB</given-names></name><name><surname>Hahn</surname><given-names>JY</given-names></name><name><surname>Choi</surname><given-names>JH</given-names></name><name><surname>Jeong</surname><given-names>DS</given-names></name><etal/></person-group><article-title>Long-term outcomes of drug-eluting stent implantation versus
coronary artery bypass grafting for patients with coronary artery disease
and chronic left ventricular systolic dysfunction</article-title><source>Am J Cardiol</source><year>2013</year><volume>112</volume><issue>5</issue><fpage>623</fpage><lpage>629</lpage><pub-id pub-id-type="doi">10.1016/j.amjcard.2013.04.035</pub-id><pub-id pub-id-type="pmid">23711811</pub-id></element-citation></ref><ref id="r5"><label>5</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Bangalore</surname><given-names>S</given-names></name><name><surname>Guo</surname><given-names>Y</given-names></name><name><surname>Samadashvili</surname><given-names>Z</given-names></name><name><surname>Blecker</surname><given-names>S</given-names></name><name><surname>Hannan</surname><given-names>EL</given-names></name></person-group><article-title>Revascularization in patients with multivessel coronary artery
disease and severe left ventricular systolic dysfunction: everolimus-eluting
stents versus coronary artery bypass graft surgery</article-title><source>Circulation</source><year>2016</year><volume>133</volume><issue>22</issue><fpage>2132</fpage><lpage>2140</lpage><pub-id pub-id-type="doi">10.1161/CIRCULATIONAHA.115.021168</pub-id><pub-id pub-id-type="pmid">27151532</pub-id></element-citation></ref><ref id="r6"><label>6</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Moher</surname><given-names>D</given-names></name><name><surname>Liberati</surname><given-names>A</given-names></name><name><surname>Tetzlaff</surname><given-names>J</given-names></name><name><surname>Altman</surname><given-names>DG</given-names></name><collab>for the PRISMA Group</collab></person-group><article-title>Preferred reporting items for systematic reviews and
metaanalyses: the PRISMA statement</article-title><source>Ann Intern Med</source><year>2009</year><volume>151</volume><issue>4</issue><fpage>264</fpage><lpage>269</lpage><pub-id pub-id-type="doi">10.7326/0003-4819-151-4-200908180-00135</pub-id><pub-id pub-id-type="pmid">19622511</pub-id></element-citation></ref><ref id="r7"><label>7</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Higgins</surname><given-names>JP</given-names></name><name><surname>Thompson</surname><given-names>SG</given-names></name><name><surname>Deeks</surname><given-names>JJ</given-names></name><name><surname>Altman</surname><given-names>DG</given-names></name></person-group><article-title>Measuring inconsistency in meta-analyses</article-title><source>BMJ</source><year>2003</year><volume>327</volume><issue>7414</issue><fpage>557</fpage><lpage>560</lpage><pub-id pub-id-type="doi">10.1136/bmj.327.7414.557</pub-id><pub-id pub-id-type="pmid">12958120</pub-id></element-citation></ref><ref id="r8"><label>8</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>DerSimonian</surname><given-names>R</given-names></name><name><surname>Kacker</surname><given-names>R</given-names></name></person-group><article-title>Random-effects model for meta-analysis of clinical trials: an
update</article-title><source>Contemp Clin Trials</source><year>2007</year><volume>28</volume><issue>2</issue><fpage>105</fpage><lpage>114</lpage><pub-id pub-id-type="doi">10.1016/j.cct.2006.04.004</pub-id><pub-id pub-id-type="pmid">16807131</pub-id></element-citation></ref><ref id="r9"><label>9</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Begg</surname><given-names>CB</given-names></name><name><surname>Mazumdar</surname><given-names>M</given-names></name></person-group><article-title>Operating characteristics of a rank correlation test for
publication bias</article-title><source>Biometrics</source><year>1994</year><volume>50</volume><issue>4</issue><fpage>1088</fpage><lpage>1101</lpage><pub-id pub-id-type="doi">10.2307/2533446</pub-id><pub-id pub-id-type="pmid">7786990</pub-id></element-citation></ref><ref id="r10"><label>10</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Egger</surname><given-names>M</given-names></name><name><surname>Davey Smith</surname><given-names>G</given-names></name><name><surname>Schneider</surname><given-names>M</given-names></name><name><surname>Minder</surname><given-names>C</given-names></name></person-group><article-title>Bias in meta-analysis detected by a simple, graphical
test</article-title><source>BMJ</source><year>1997</year><volume>315</volume><issue>7109</issue><fpage>629</fpage><lpage>634</lpage><pub-id pub-id-type="doi">10.1136/bmj.315.7109.629</pub-id><pub-id pub-id-type="pmid">9310563</pub-id></element-citation></ref><ref id="r11"><label>11</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Shah</surname><given-names>S</given-names></name><name><surname>Benedetto</surname><given-names>U</given-names></name><name><surname>Caputo</surname><given-names>M</given-names></name><name><surname>Angelini</surname><given-names>GD</given-names></name><name><surname>Vohra</surname><given-names>HA</given-names></name></person-group><article-title>Comparison of the survival between coronary artery bypass graft
surgery versus percutaneous coronary intervention in patients with poor left
ventricular function (ejection fraction &#x00026;lt; 30%): a propensity-matched
analysis</article-title><source>Eur J Cardiothorac Surg</source><year>2019</year><volume>55</volume><issue>2</issue><fpage>238</fpage><lpage>246</lpage><pub-id pub-id-type="doi">10.1093/ejcts/ezy236</pub-id><pub-id pub-id-type="pmid">29933433</pub-id></element-citation></ref><ref id="r12"><label>12</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Hawranek</surname><given-names>M</given-names></name><name><surname>Zembala</surname><given-names>MO</given-names></name><name><surname>Gasior</surname><given-names>M</given-names></name><name><surname>Hrapkowicz</surname><given-names>T</given-names></name><name><surname>Pyka</surname><given-names>L</given-names></name><name><surname>Ciesla</surname><given-names>D</given-names></name><etal/></person-group><article-title>Comparison of coronary artery bypass grafting and percutaneous
coronary intervention in patients with heart failure with reduced ejection
fraction and multivessel coronary artery disease</article-title><source>Oncotarget</source><year>2018</year><volume>9</volume><issue>30</issue><fpage>21201</fpage><lpage>21210</lpage><pub-id pub-id-type="doi">10.18632/oncotarget.25006</pub-id><pub-id pub-id-type="pmid">29765531</pub-id></element-citation></ref><ref id="r13"><label>13</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Iribarne</surname><given-names>A</given-names></name><name><surname>DiScipio</surname><given-names>AW</given-names></name><name><surname>Leavitt</surname><given-names>BJ</given-names></name><name><surname>Baribeau</surname><given-names>YR</given-names></name><name><surname>McCullough</surname><given-names>JN</given-names></name><name><surname>Weldner</surname><given-names>PW</given-names></name><etal/></person-group><article-title>Comparative effectiveness of coronary artery bypass grafting
versus percutaneous coronary intervention in a real-world surgical treatment
for ischemic heart failure trial population</article-title><source>J Thorac Cardiovasc Surg</source><year>2018</year><volume>156</volume><issue>4</issue><fpage>1410</fpage><lpage>1421</lpage><pub-id pub-id-type="doi">10.1016/j.jtcvs.2018.04.121</pub-id><pub-id pub-id-type="pmid">29961592</pub-id></element-citation></ref><ref id="r14"><label>14</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Lee</surname><given-names>SE</given-names></name><name><surname>Lee</surname><given-names>HY</given-names></name><name><surname>Cho</surname><given-names>HJ</given-names></name><name><surname>Choe</surname><given-names>WS</given-names></name><name><surname>Kim</surname><given-names>H</given-names></name><name><surname>Choi</surname><given-names>JO</given-names></name><etal/></person-group><article-title>Coronary artery bypass graft versus percutaneous coronary
intervention in acute heart failure</article-title><source>Heart</source><year>2018</year><!--<pub-id pub-id-type="pii">heartjnl-2018-313242</pub-id>--><pub-id pub-id-type="doi">10.1136/heartjnl-2018-313242</pub-id></element-citation></ref><ref id="r15"><label>15</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Kim</surname><given-names>MS</given-names></name><name><surname>Kang</surname><given-names>SH</given-names></name><name><surname>Park</surname><given-names>H</given-names></name><name><surname>Bae</surname><given-names>BJ</given-names></name><name><surname>Cheon</surname><given-names>SS</given-names></name><name><surname>Roh</surname><given-names>JH</given-names></name><etal/></person-group><article-title>TCTAP A-035 a. Left main revascularization for patients with
reduced left ventricular ejection fraction; Comparison of outcome after PCI
versus CABG from ASAN-MAIN Registry</article-title><source>J Am Coll Cardiol.</source><year>2015</year><volume>65</volume><issue>17 Suppl S18</issue><pub-id pub-id-type="doi">10.1016/j.jacc.2015.03.087</pub-id></element-citation></ref><ref id="r16"><label>16</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Park</surname><given-names>HS</given-names></name><name><surname>Roh</surname><given-names>JH</given-names></name><name><surname>Lee</surname><given-names>PH</given-names></name><name><surname>Chang</surname><given-names>M</given-names></name><name><surname>Yoon</surname><given-names>SH</given-names></name><name><surname>Ahn</surname><given-names>JM</given-names></name><etal/></person-group><article-title>TCT-481 Percutaneous coronary intervention versus coronary-artery
bypass grafting for left main coronary disease with reduced left ventricular
ejection fraction</article-title><source>J Am Coll Cardiol</source><year>2015</year><volume>66</volume><issue>15 Suppl</issue><fpage>B196</fpage><lpage>B197</lpage><pub-id pub-id-type="doi">10.1016/j.jacc.2015.08.497</pub-id></element-citation></ref><ref id="r17"><label>17</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Marui</surname><given-names>A</given-names></name><name><surname>Kimura</surname><given-names>T</given-names></name><name><surname>Nishiwaki</surname><given-names>N</given-names></name><name><surname>Mitsudo</surname><given-names>K</given-names></name><name><surname>Komiya</surname><given-names>T</given-names></name><name><surname>Hanyu</surname><given-names>M</given-names></name><etal/></person-group><article-title>Comparison of five-year outcomes of coronary artery bypass
grafting versus percutaneouscoronary intervention in patients with left
ventricular ejection fractions = 50% versus &#x00026;gt;50% (from the
CREDO-Kyoto PCI/CABG Registry Cohort-2)</article-title><source>Am J Cardiol</source><year>2014</year><volume>114</volume><issue>7</issue><fpage>988</fpage><lpage>996</lpage><pub-id pub-id-type="doi">10.1016/j.amjcard.2014.07.007</pub-id><pub-id pub-id-type="pmid">25124184</pub-id></element-citation></ref><ref id="r18"><label>18</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Nagendran</surname><given-names>J</given-names></name><name><surname>Norris</surname><given-names>CM</given-names></name><name><surname>Graham</surname><given-names>MM</given-names></name><name><surname>Ross</surname><given-names>DB</given-names></name><name><surname>Macarthur</surname><given-names>RG</given-names></name><name><surname>Kieser</surname><given-names>TM</given-names></name><etal/></person-group><article-title>Coronary revascularization for patients with severe left
ventricular dysfunction</article-title><source>Ann Thorac Surg</source><year>2013</year><volume>96</volume><issue>6</issue><fpage>2038</fpage><lpage>2044</lpage><pub-id pub-id-type="doi">10.1016/j.athoracsur.2013.06.052</pub-id><pub-id pub-id-type="pmid">23968761</pub-id></element-citation></ref><ref id="r19"><label>19</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Fortuna</surname><given-names>D</given-names></name><name><surname>Nicolini</surname><given-names>F</given-names></name><name><surname>Guastaroba</surname><given-names>P</given-names></name><name><surname>De Palma</surname><given-names>R</given-names></name><name><surname>Di Bartolomeo</surname><given-names>S</given-names></name><name><surname>Saia</surname><given-names>F</given-names></name><etal/></person-group><article-title>Coronary artery bypassgrafting vs percutaneous coronary
intervention in a &#x0201c;real-world&#x0201d; setting: a comparative effectiveness study
based on propensity score-matched cohorts</article-title><source>Eur J Cardiothorac Surg</source><year>2013</year><volume>44</volume><issue>1</issue><fpage>e16</fpage><lpage>e24</lpage><pub-id pub-id-type="doi">10.1093/ejcts/ezt197</pub-id><pub-id pub-id-type="pmid">23628951</pub-id></element-citation></ref><ref id="r20"><label>20</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>LaBarbera</surname><given-names>M</given-names></name><name><surname>Hui</surname><given-names>P</given-names></name><name><surname>Shaw</surname><given-names>R</given-names></name></person-group><article-title>Coronary artery disease in patients with reduced left ventricular
systolic function treated with medicine, surgery, or percutaneous coronary
intervention: a retrospective review of outcomes within a multicenter
healthcare system</article-title><source>J Am Coll Cardiol.</source><year>2012</year><volume>60</volume><issue>17</issue><pub-id pub-id-type="doi">10.1016/j.jacc.2012.08.400</pub-id></element-citation></ref><ref id="r21"><label>21</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Cleland</surname><given-names>JG</given-names></name><name><surname>Calvert</surname><given-names>M</given-names></name><name><surname>Freemantle</surname><given-names>N</given-names></name><name><surname>Arrow</surname><given-names>Y</given-names></name><name><surname>Ball</surname><given-names>SG</given-names></name><name><surname>Bonser</surname><given-names>RS</given-names></name><etal/></person-group><article-title>The heart failure revascularisation trial (HEART)</article-title><source>Eur J Heart Fail</source><year>2011</year><volume>13</volume><issue>2</issue><fpage>227</fpage><lpage>233</lpage><pub-id pub-id-type="doi">10.1093/eurjhf/hfq230</pub-id><pub-id pub-id-type="pmid">21156659</pub-id></element-citation></ref><ref id="r22"><label>22</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Ahn</surname><given-names>JM</given-names></name><name><surname>Park</surname><given-names>DW</given-names></name><name><surname>Park</surname><given-names>GM</given-names></name><name><surname>Kim</surname><given-names>YG</given-names></name><name><surname>Choi</surname><given-names>HO</given-names></name></person-group><article-title>TCT-326: Comparisons of drug-eluting stents vs. coronary-artery
bypass grafting for patients with multi-vessel disease and severely
compromised ventricular dysfunction</article-title><source>J Am Coll Cardiol.</source><year>2010</year><volume>56</volume><issue>13 Suppl</issue><pub-id pub-id-type="doi">10.1016/j.jacc.2010.08.353</pub-id></element-citation></ref><ref id="r23"><label>23</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Hannan</surname><given-names>EL</given-names></name><name><surname>Wu</surname><given-names>C</given-names></name><name><surname>Walford</surname><given-names>G</given-names></name><name><surname>Culliford</surname><given-names>AT</given-names></name><name><surname>Gold</surname><given-names>JP</given-names></name><name><surname>Smith</surname><given-names>CR</given-names></name><etal/></person-group><article-title>Drug-eluting stents vs. coronary-artery bypass grafting in
multivessel coronary disease</article-title><source>N Engl J Med</source><year>2008</year><volume>358</volume><fpage>331</fpage><lpage>341</lpage><pub-id pub-id-type="doi">10.1056/NEJMoa071804</pub-id><pub-id pub-id-type="pmid">18216353</pub-id></element-citation></ref><ref id="r24"><label>24</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Gioia</surname><given-names>G</given-names></name><name><surname>Matthai</surname><given-names>W</given-names></name><name><surname>Gillin</surname><given-names>K</given-names></name><name><surname>Dralle</surname><given-names>J</given-names></name><name><surname>Benassi</surname><given-names>A</given-names></name><name><surname>Gioia</surname><given-names>MF</given-names></name><etal/></person-group><article-title>Revascularization in severe left ventricular dysfunction: outcome
comparison of drug-eluting stent implantation versus coronary artery by-pass
grafting</article-title><source>Catheter Cardiovasc Interv</source><year>2007</year><volume>70</volume><issue>1</issue><fpage>26</fpage><lpage>33</lpage><pub-id pub-id-type="doi">10.1002/ccd.21072</pub-id><pub-id pub-id-type="pmid">17585381</pub-id></element-citation></ref><ref id="r25"><label>25</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Buszman</surname><given-names>P</given-names></name><name><surname>Szkr&#x000f3;bka</surname><given-names>I</given-names></name><name><surname>Gruszka</surname><given-names>A</given-names></name><name><surname>Parma</surname><given-names>R</given-names></name><name><surname>Tendera</surname><given-names>Z</given-names></name><name><surname>Lesko</surname><given-names>B</given-names></name><etal/></person-group><article-title>Comparison of effectivenesse of coronary artery bypass grafting
versus percutaneous coronary intervention in patients with ischemic
cardiomyopathy</article-title><source>Am J Cardiol</source><year>2007</year><volume>99</volume><issue>1</issue><fpage>36</fpage><lpage>41</lpage><pub-id pub-id-type="doi">10.1016/j.amjcard.2006.07.056</pub-id><pub-id pub-id-type="pmid">17196458</pub-id></element-citation></ref><ref id="r26"><label>26</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Brener</surname><given-names>SJ</given-names></name><name><surname>Lytle</surname><given-names>BW</given-names></name><name><surname>Casserly</surname><given-names>IP</given-names></name><name><surname>Schneider</surname><given-names>JP</given-names></name><name><surname>Topol</surname><given-names>EJ</given-names></name><name><surname>Lauer</surname><given-names>MS</given-names></name></person-group><article-title>Propensity analysis of long-term survival after surgical or
percutaneous revascularization in patients with multivessel coronary artery
disease and high-risk features</article-title><source>Circulation</source><year>2004</year><volume>109</volume><issue>19</issue><fpage>2290</fpage><lpage>2295</lpage><pub-id pub-id-type="doi">10.1161/01.CIR.0000126826.58526.14</pub-id><pub-id pub-id-type="pmid">15117846</pub-id></element-citation></ref><ref id="r27"><label>27</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Sedlis</surname><given-names>SP</given-names></name><name><surname>Ramanathan</surname><given-names>KB</given-names></name><name><surname>Morrison</surname><given-names>DA</given-names></name><name><surname>Sethi</surname><given-names>G</given-names></name><name><surname>Sacks</surname><given-names>J</given-names></name><name><surname>Henderson</surname><given-names>W</given-names></name></person-group><article-title>Outcome of percutaneous coronary intervention versus coronary
bypass grafting for patients with low left ventricular ejection fractions,
unstable angina pectoris, and risk factors for adverse outcomes with bypass
(the AWESOME randomized trial and registry)</article-title><source>Am J Cardiol</source><year>2004</year><volume>94</volume><issue>1</issue><fpage>118</fpage><lpage>120</lpage><pub-id pub-id-type="doi">10.1016/j.amjcard.2004.03.041</pub-id><pub-id pub-id-type="pmid">15219521</pub-id></element-citation></ref><ref id="r28"><label>28</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Toda</surname><given-names>K</given-names></name><name><surname>Mackenzie</surname><given-names>K</given-names></name><name><surname>Mehra</surname><given-names>MR</given-names></name><name><surname>DiCorte</surname><given-names>CJ</given-names></name><name><surname>Davis</surname><given-names>JE</given-names></name><name><surname>McFadden</surname><given-names>PM</given-names></name><etal/></person-group><article-title>Revascularization in severe ventricular dysfunction (15% &#x00026;lt;
OR = LVEF &#x00026;lt; OR = 30%): a comparison of bypass grafting and
percutaneous intervention</article-title><source>Ann Thorac Surg</source><year>2002</year><volume>74</volume><issue>6</issue><fpage>2082</fpage><lpage>2087</lpage><pub-id pub-id-type="doi">10.1016/s0003-4975(02)04120-6</pub-id><comment>discussion 2087</comment><pub-id pub-id-type="pmid">12643399</pub-id></element-citation></ref><ref id="r29"><label>29</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Hlatky</surname><given-names>MA</given-names></name><name><surname>Boothroyd</surname><given-names>DB</given-names></name><name><surname>Bravata</surname><given-names>DM</given-names></name><name><surname>Boersma</surname><given-names>E</given-names></name><name><surname>Booth</surname><given-names>J</given-names></name><name><surname>Brooks</surname><given-names>MM</given-names></name><etal/></person-group><article-title>Coronary artery bypass surgery compared with percutaneous
coronary interventions for multivessel disease: a collaborative analysis of
individual patient data from ten randomised trials</article-title><source>Lancet</source><year>2009</year><volume>373</volume><issue>9670</issue><fpage>1190</fpage><lpage>1197</lpage><pub-id pub-id-type="doi">10.1016/S0140-6736(09)60552-3</pub-id><pub-id pub-id-type="pmid">19303634</pub-id></element-citation></ref><ref id="r30"><label>30</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Palmerini</surname><given-names>T</given-names></name><name><surname>Biondi-Zoccai</surname><given-names>G</given-names></name><name><surname>Reggiani</surname><given-names>LB</given-names></name><name><surname>Sangiorgi</surname><given-names>D</given-names></name><name><surname>Alessi</surname><given-names>L</given-names></name><name><surname>De Servi</surname><given-names>S</given-names></name><etal/></person-group><article-title>Risk of stroke with coronary artery bypass graft surgery compared
with percutaneous coronary intervention</article-title><source>J Am Coll Cardiol</source><year>2012</year><volume>60</volume><issue>9</issue><fpage>798</fpage><lpage>805</lpage><pub-id pub-id-type="doi">10.1016/j.jacc.2011.10.912</pub-id><pub-id pub-id-type="pmid">22917004</pub-id></element-citation></ref><ref id="r31"><label>31</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Head</surname><given-names>SJ</given-names></name><name><surname>Milojevic</surname><given-names>M</given-names></name><name><surname>Daemen</surname><given-names>J</given-names></name><name><surname>Ahn</surname><given-names>JM</given-names></name><name><surname>Boersma</surname><given-names>E</given-names></name><name><surname>Christiansen</surname><given-names>EH</given-names></name><etal/></person-group><article-title>Stroke rates following surgical versus percutaneous coronary
revascularization</article-title><source>J Am Coll Cardiol</source><year>2018</year><volume>72</volume><issue>4</issue><fpage>386</fpage><lpage>398</lpage><pub-id pub-id-type="doi">10.1016/j.jacc.2018.04.071</pub-id><pub-id pub-id-type="pmid">30025574</pub-id></element-citation></ref></ref-list></back><floats-group><fig id="f8" orientation="portrait" position="float"><graphic xlink:href="rbccv-34-04-0396-g08"/></fig></floats-group></article>